Multiple Myeloma
Multiple Myeloma
Advertisement
Elaine S. DeMeyer, RN, MSN, AOCN®, BMTCN®Multiple Myeloma | February 21, 2024
As the care team members with the most patient contact, oncology nurses must understand shared decision-making.
Read More
Elaine S. DeMeyer, RN, MSN, AOCN®, BMTCN®Multiple Myeloma | February 21, 2024
As patients may be considering or receiving anti-BCMA therapy, oncology nurses need to be able to explain this target.
Cecilia BrownMultiple Myeloma | January 31, 2024
Most patients who switched to a reduced frequency or reduced dose showed deepened or maintained responses to treatment.
Cecilia BrownMultiple Myeloma | February 5, 2024
Previous analyses have suggested system-level and patient-level barriers limit patient access to precision oncology options.
Cecilia BrownMultiple Myeloma | January 31, 2024
A nurse navigator assessed financial and transportation barriers, coordinated resources, and performed outreach.
Cecilia BrownMultiple Myeloma | January 31, 2024
Previous research showed that only 10% of older patients with hematological malignancies received a geriatric assessment.
Cecilia BrownMultiple Myeloma | February 14, 2024
It was important to develop the model because outcomes are heterogenous, with overall survival ranging from months to years.
Cecilia BrownHematology & Blood Cancer | January 15, 2024
Researchers developed and piloted a novel phone-delivered positive psychology intervention called PATH.
Cecilia BrownHematology & Blood Cancer | January 4, 2024
Anastasia Marie Santiago, DNP, APRN, FNP-BC, AOCNP, shares her experiences and several critical pieces of advice.
Cecilia BrownTreatment | December 21, 2023
A randomized controlled trial evaluated an educational video on CAR-T in adults who were receiving the therapy.
Cecilia BrownConferences | November 20, 2023
Researchers surveyed patients using the HealthTree Cure Hub, which is a patient-driven clinical cancer information platform.
Cecilia BrownConferences | November 20, 2023
Researchers surveyed patients with multiple myeloma to gain insights into their decision-making process.
Cecilia BrownConferences | November 13, 2023
Speakers from the JADPRO Live session on myeloma share what they hope to see happen in the future.
Cecilia BrownConferences | January 11, 2024
Rachid Baz, MD, and Elizabeth Finley-Oliver, MSN, ARNP, AGNP-BC, delivered a presentation on the topic at JADPRO Live 2023.
Cancer Nursing Today EditorsConferences | November 10, 2023
Patients with relapsed or refractory multiple myeloma are at an increased risk for severe infections.
Cancer Nursing Today EditorsConferences | November 10, 2023
Researchers conducted a pooled analysis of the MagnetisMM studies.
Cancer Nursing Today EditorsConferences | November 9, 2023
Nurses involved with the MajesTEC-1 study recommended several practices for infection monitoring and management.
Cecilia BrownConferences | November 9, 2023
The survey received responses from 100 patients with multiple myeloma and 200 APPs who treat patients with the disease.
Cancer Nursing Today EditorsConferences | November 7, 2023
In addition, deepened or sustained responses were also seen in patients who went from weekly to biweekly elranatamab.
Cancer Nursing Today EditorsConferences | November 7, 2023
The Right Track educational program, created by The Multiple Myeloma Research Foundation, includes 3 critical components.
Advertisement
Advertisement
Advertisement